Free Delivery Over $100
|
|
|||
|
||||
OverviewRising health care costs have for many years focused congressional attention upon the development and availability of prescription drugs. Recently, the presence of ""authorised generic"" pharmaceuticals in the drug marketplace has been the subject of congressional concern. An ""authorised generic"" is a pharmaceutical that is marketed by or on behalf of a brand-named drug company, but is sold under a generic name. The brand-name firm may distribute the drug under its own auspices or via a license to a generic drug company. The price of this ""authorised copy"" is ordinarily lower than that of the brand-name drug. Some sources refer to authorised generics as ""branded,"" ""flanking,"" or ""pseudo"" generics."" This book presents an analysis of the innovation and public health issues relating to authorised generic drugs beginning with a review of the procedures through which independent generic drug companies receive government permission to market their products and resolve patent disputes with brand-name firms and consumer welfare. Full Product DetailsAuthor: Edward R Nelson , Jerry G WrightPublisher: Nova Science Publishers Inc Imprint: Nova Science Publishers Inc Weight: 0.560kg ISBN: 9781622570751ISBN 10: 1622570758 Pages: 216 Publication Date: 13 November 2012 Audience: Professional and scholarly , Professional & Vocational Format: Hardback Publisher's Status: Active Availability: In stock  We have confirmation that this item is in stock with the supplier. It will be ordered in for you and dispatched immediately. Table of ContentsPreface; Authorized Generic Drugs: Short-Term Effects & Long-Term Impact; Authorized Generic Pharmaceuticals: Effects on Innovation; Index.ReviewsAuthor InformationTab Content 6Author Website:Countries AvailableAll regions |
||||
